+44 1478 350008Cell & Developmental Biology : Citations & Metrics Report
Articles published in Cell & Developmental Biology have been cited by esteemed scholars and scientists all around the world. Cell & Developmental Biology has got h-index 15, which means every article in Cell & Developmental Biology has got 15 average citations.
Following are the list of articles that have cited the articles published in Cell & Developmental Biology.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Total published articles |
29 | 30 | 26 | 5 | 8 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
123 | 142 | 124 | 118 | 105 |
| Journal total citations count | 951 |
| Journal impact factor | 5.1 |
| Journal 5 years impact factor | 6.8 |
| Journal cite score | 7.0 |
| Journal h-index | 15 |
| Journal h-index since 2019 | 12 |
Important citations (614)
Lu dy, lu tr, cao s, yarla ns, lu y. life origin on earth, what is the right answer. int j mol biol open access. 2017;2(2):00017. |
|
Lu dy, wu hy, lu tr, che jy, lu y. updating biomedical studies by recruiting more mathematics or physics-majored talents. metabolomics. 2016;6(2):e148. |
|
Košarić j. ispitivanje molekularnih mehanizama dejstva nekih organoselenskih jedinjenja na redoks status ćelija kancera kolona nst-116 i dojke mda-mb-2314 (doctoral dissertation, Универзитет у Крагујевцу, Природно-математички факултет). |
|
Elbur ai, yousif ma, albarraq aa, abdallah ma. pharmacy practice & drug research. |
|
Kundu a, dey p, banerjee s, sarkar p, de a, maity a, kim hs. 5 heparin and its derivatives-based nanoparticles for cancer therapy. polysaccharide based nano-biocarrier in drug delivery. 2018 sep 3:81-104. |
|
Dasgupta s, roy s, chakraborty t, sarkar n. polysaccharide-based nanocarriers loaded with drugs for the management of obesity. inpolysaccharide based nano-biocarrier in drug delivery 2018 sep 3 (pp. 339-360). crc press. |
|
Lu dy, lu tr, xu b, varki a, huang m, zhu h, shen y, yarla ns. aberrant sialylation in cancer pathology and metastasis, a putative drug target candidate. anti-cancer agents in medicinal chemistry (formerly current medicinal chemistry-anti-cancer agents). 2018 nov 1;18(14):1952-61. |
|
Hassan ba. concepts of anticancer treatment and pharmacogenomics in cancer treatments. frontiers in anti-cancer drug discovery. 2015 may 5;5:64. |
|
Lu dy, chen eh, lu tr, ding j, xu b. innovations in pharmaceuticals and pharmacotherapy. |
|
Lu dy, lu tr, wu hy. journal of clinical and experimental pharmacology. |
|
Mahasa kj. mathematical modelling of drug resistance in malignant tumour treatment (doctoral dissertation). |
|
Lu dy, lu tr, chen eh, yarla ns, xu b, ding j, huang m, zhu h. keep u p the pace of drug development evolution and expenditure. cancer rep rev. 2018 sep 26;2(5):165. |
|
Lu dy, lu tr, xu b, che jy, wu sy, wu hy, yarla ns. anti-metastatic drug development, work out towards new direction. med chem (los angeles). 2018;8:192-6. |
|
Lu dy, lu tr, xu b, ding j, chen eh, wu hy, wu sy, yarla ns, zhu h. antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot. clin. proteom. bioinform. 2017;2(1):118. |
|
Lu dy, lu tr, xu b, ding j, lu y, yarla ns. perspective of personalized cancer therapy. drug therapy. 2017;10(1):44-55. |
|
Lu dy, lu tr, xu b, che jy, shen y, yarla ns. individualized cancer therapy, future approaches. current pharmacogenomics and personalized medicine (formerly current pharmacogenomics). 2018 jun 1;16(2):156-63. |
|
Lu dy, lu tr, xu b, ding j, yarla ns. general topics in the field of personalized cancer therapy. metabolomics (los angels). 2018;8:e156. |
|
Lu dy, lu tr, xu b, ding j, yarla ns. clinical cancer therapy, personalized chemotherapies. j cell dev biol. 2017;1(1):5. |
|
Lu dy, qu rx, lu tr, wu hy. cancer bioinformatics for updating anticancer drug developments and personalized therapeutics. reviews on recent clinical trials. 2017 jun 1;12(2):101-10. |
|
Lu dy, xu j, lu tr, wu hy, xu b. inhibitions of several antineoplastic drugs on serum sialic acid levels in mice bearing tumors. scientia pharmaceutica. 2013 mar;81(1):223-32. |
|